Top Markets
Coin of the day
GridAI Technologies Corp. GridAI Technologies Corp.

GridAI Technologies Corp.

GRDX
Rang in Aktien #31396
GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical... GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical enterprise primarily dedicated to developing precise, locally-acting treatments for various digestive system ailments. Its core activity involves researching and advancing therapeutic solutions specifically designed for patients with gastrointestinal diseases. The company's pipeline features several key drug candidates, including Latiglutenase, Capeserod, Adrulipase, and Niclosamide. GridAI Technologies was established on January 30, 2014, and maintains its principal offices in Boca Raton, Florida.
Aktienkurs
$3.95
Zuletzt synchronisiert: 2026-08-17
Marktkapitalisierung
$13.28M
Veränderung (1 Tag)
-5.28%
Veränderung (1 Jahr)
82.87%
Land
US
Handel GridAI Technologies Corp. (GRDX)

Kategorie

Dividendenrendite-Verlauf für GridAI Technologies Corp. (GRDX)
Dividendenrendite (TTM) von GridAI Technologies Corp. (Aktienkürzel: GRDX) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für GridAI Technologies Corp. (GRDX) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber